Epidemiology of Hepatitis C Virus
Authors:
- Cladd E. StevensCSCladd E. Stevens
- Patricia E. TaylorPTPatricia E. Taylor
- Johanna PindyckJPJohanna Pindyck
- Qui-Lim ChooQCQui-Lim Choo
- Daniel W. BradleyDBDaniel W. Bradley
- George KuoGKGeorge Kuo
- Michael HoughtonMHMichael Houghton
- 5 January 1990
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 263 (1) , 49-53
Abstract
In a survey carried out from 1985 through 1986, volunteer blood donors to The Greater New York Blood Program were tested for two surrogate markers for nonA, non-B hepatitis—elevation of alanine aminotransferase level and presence of antibody to hepatitis B core antigen. Stored serum samples from selected donors were also recently tested for antibody to hepatitis C virus (anti-HCV). Anti-HCV was detected in 0.9% to 1.4% of donors and was higher in black and Hispanic donors than in white donors. Anti-HCV prevalence increased with increasing age through the fourth decade of life, but decreased thereafter, possibly reflecting the disappearance of detectable antibody with time. Anti-HCV correlated with both alanine aminotransferase level and the presence or absence of antibody to hepatitis B core antigen. These associations suggest that donor screening for elevation of alanine aminotransferase level and presence of antibody to hepatitis B core antigen was, as expected, at least partially effective in preventing transfusion-associated non-A, non-B hepatitis. The detection of anti-HCV in donors who have neither an elevation of alanine aminotransferase level nor presence of antibody to hepatitis B core antigen suggests that donor screening for anti-HCV will further reduce the risk of transfusion-associated hepatitis. (JAMA. 1990;263:49-53)Keywords
This publication has 5 references indexed in Scilit:
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989
- A review of recent events related to surrogate testing of blood to prevent non‐A, non‐B posttransfusion hepatitisTransfusion, 1987
- Donor transaminase and recipient hepatitis. Impact on blood transfusion servicesJAMA, 1981
- EFFICACY OF PROPHYLACTIC GAMMA-GLOBULIN IN PREVENTING NON-A, NON-B POST-TRANSFUSION HEPATITISThe Lancet, 1976
- CLINICAL AND SEROLOGICAL ANALYSIS OF TRANSFUSION-ASSOCIATED HEPATITISThe Lancet, 1975